Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2016 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics Announces Second Quarter 2016 Financial Results

WALTHAM, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
June 15, 2016 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd

WALTHAM, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients...
May 09, 2016 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics Announces First Quarter 2016 Financial Results

WALTHAM, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
April 28, 2016 07:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis Patients

WALTHAM, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
April 13, 2016 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery Disease

WALTHAM, Mass., April 13, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
March 14, 2016 08:30 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results

WALTHAM, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
March 02, 2016 17:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8th

WALTHAM, Mass., March 02, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
February 02, 2016 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8th

WALTHAM, Mass., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients...
December 02, 2015 08:00 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics to Present at the Oppenheimer 26th Annual Healthcare Conference December 9th

WALTHAM, Mass., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
November 13, 2015 07:45 ET | Source: Proteon Therapeutics, Inc.

Proteon Therapeutics to Present at the Stifel 2015 Healthcare Conference on November 17th

WALTHAM, Mass., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right